An Open-Label, Multicentre, Single Arm Phase II Study Of Oral GW572016 As Single Agent Therapy In Subjects With Advanced Or Metastatic Breast Cancer Who Have Progressed While Receiving Herceptin-Containing Regiments

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleAn Open-Label, Multicentre, Single Arm Phase II Study Of Oral GW572016 As Single Agent Therapy In Subjects With Advanced Or Metastatic Breast Cancer Who Have Progressed While Receiving Herceptin-Containing Regiments
StatusFinished
Effective start/end date1/04/04 → 31/03/07

Funding

  • GlaxoSmithKline